Zeno Health 
Dealstreet

Argus Partners advises Zeno Health on Series C fundraise

Zeno Health raised approximately ₹207.3 crore ($250 million) from this fundraise.

Bar & Bench

Zeno Health has raised approximately ₹207.3 crore ($250 million) from a Series C fundraise led by South Korean private equity investor STIC Investments, with significant participation from existing investor, Lightbox Ventures.

Argus Partners advised Zeno Health on this fundraise.

The transaction team consisted of Abhinav Bhalaik (Partner), Neha Madan (Partner), Rohan Aneja (Associate), Abhishek Tripathy (Associate) and Tanya Nair (Associate).

Abhinav Bhalaik, Neha Madan

Zeno Health is a health-tech startup and omnichannel pharmacy platform for generic and branded medicines. The company aims to utilize the latest capital infusion to expand its footprint and enhance its technological infrastructure. Further, the investment will also empower Zeno Health, in making quality healthcare affordable to all and serve nearly 1 (one) crore consumers monthly.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Courtroom of 2050: Culture and trends

From ‘rizz’ to ‘rights’: When slang meets black letter law

Humiliating: Allahabad High Court sets aside direction to student to hold placard promising 'not to misbehave with girls'

Mumbai court refuses to stay release of movie O'Romeo

Kerala High Court calls for review of rule imposing blanket ban on non-Hindus in temples

SCROLL FOR NEXT